SavedAdd your journal

Journals / Harran Üniversitesi Tıp Fakültesi Dergisi / 2016 / Cilt: 13 - Sayı: 3

The Relationship Between Type 2 DM Patients With Serum Uric Acid And Gamma Glutamyl Transferase Levels and Development Coronary Artery Disease

Tip II Diyabetes Mellituslu Hastalarda Serum Ürik Asit Ve Gama Glutamil Transferaz Düzeyleri İle Koroner Arter Hastalığı Gelişimi Arasındaki İlişki

Ekrem AKSU
Deniz AVCI
Gürkan ÇIKIM
Yunus ÇELİK
Pages
231–236
Publication Date
2016-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, SUAlevels in type II DM are not have a relation with the risk of CAD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study we prospectively compared the patients with coronary artery disease (CAD) accompanied type 2 diabetes mellitus (DM) and patients followed with type 2 diabetes in view of the serum uric acid (SUA) and glutamil gamma transferase (GGT) levels furthermore metabolic parameters; it is targeted to reveal the relationship between these parameters and CAD development risk in diabetic patients.
📊
Key Findings & Data:Materials-Methods: 118 patients with type ll DM and 222 type 2 DM patients with CAD who were applied to the cardiology output clinic enrolled to the study.
💡
Conclusion & Impact:However, SUAlevels in type II DM are not have a relation with the risk of CAD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ürik Asid · Gama glutamil Transferaz · Tip II Diyabetes Mellitus

Abstract

Objective: In this study we prospectively compared the patients with coronary artery disease (CAD) accompanied type 2 diabetes mellitus (DM) and patients followed with type 2 diabetes in view of the serum uric acid (SUA) and glutamil gamma transferase (GGT) levels furthermore metabolic parameters; it is targeted to reveal the relationship between these parameters and CAD development risk in diabetic patients. Materials-Methods: 118 patients with type ll DM and 222 type 2 DM patients with CAD who were applied to the cardiology output clinic enrolled to the study. Results: No significant difference was established between groups for SUAlevels (5.37 ± 1,48 vs 5.27±1,51 mg/dl; p=0,194) , while the GGT levels in CAD with type ll DM detected statistically significent higher than type II DM group(23.0 (16,0-32,50) vs 25 (18,0-39,0)U/L; P< 0,001). Conclusion: We observed serum GGTlevels in DM patients are a predictor of the raising cardiovascular risk. However, SUAlevels in type II DM are not have a relation with the risk of CAD.

Özet

Amaç: Çalışmamızda koroner arter hastalığının (KAH) eşlik ettiği tip 2 diyabetesmellituslu (DM) hastalarla tip 2 DM tanısıyla takip edilen hastalar serum ürik asit (SÜA) ve gama glutamiltransferaz (GGT) düzeyleri diğer metabolik parametreler ile birlikte incelenerek prospektif olarak karşılaştırılmış; diyabetik hastalarda bu parametreler ile KAH gelişimi arasındaki ilişki ortaya koymak amaçlanmıştır. Gereç ve Yöntem: Kahramanmaraş Necip Fazıl Şehir Hastanesi\'nde gerçekleştirilen bu çalışmaya, kardiyoloji polikliniğine başvuran tip II DM'lI 118 hasta, KAH\'nın eşlik ettiği 222 adet tip 2 DM\'li hasta dahil edildi. Bulgular: Guruplar arasında SÜA düzeylerinde anlamlı farkın olmadığı (5.37±1.48 vs 5.27±1.51 mg/dl; p=0.194), GGT düzeyinin ise tip II DM'nin eşlik ettiği KAH olan grupta sadece tip II DM olan gruba göre istatistiki olarak anlamlı olarak daha yüksek olduğunu tespit ettik(23,0 (16,0-32,50) vs 25 (18,0-39,0) U/L; P < 0,0001). Sonuç: Çalışmamızda serum GGTdüzeyinin diyabetli hastalarda kardiyovasküler riskin artışını gösteren bir prediktör olabileceğini gözlemledik. Ancak SÜAseviyesiyle tip II DM'li hastalarda KAH riski arasında ilişki saptanamamıştır

🔖

Cite This Article

AKSU, E., AVCI, D., ÇIKIM, G., ÇELİK, Y. (2016). The Relationship Between Type 2 DM Patients With Serum Uric Acid And Gamma Glutamyl Transferase Levels and Development Coronary Artery Disease. Harran Üniversitesi Tıp Fakültesi Dergisi, Cilt: 13 - Sayı: 3, 231–236. https://ajindex.com/articles/22483

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Solberg LA, Enger SC, Hjermann I, et al. Risk factors for coronary and cerebral atherosclerosis in Oslo Study. In: Gotto AM, Smith LC, Allen B AD AL. Atherosclerosis V. New York, NY: Springer Verlag
  2. American Diabetes Association. Standards of medicalcare in diabetes-2008. Diabetes Care 2008
  3. 31 Suppl 1:12-54. 3.Stamler J, Caccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial (MRFIT). Diabetes Care 1993
  4. Ruttmann E, Brant LJ, Concin H ve ark.Vorarlberg health monitoring and promotion program study group. Gamma-glutamyl transferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrianadults. Circulation. 2005
  5. Pompella A, Emdin M, Passino C et al. Thesignificance of serum gamma-glutamyl transferase in cardiovascular diseases. Clin Chem Lab Med. 2004
  6. Meisinger C, Döring A, Schneider A. Serum gammaglutamyl transferase is a predictor of incident coronary events in apparently healthy men fromthe general population. Atherosclerosis 2006
  7. Turgut O, Yilmaz A, Yalta K ve ark. Gamma glutamyl transferase is a promising biomarker for cardiovascular risk. MedHypotheses 2006
  8. Ndrepepa G, Braun S, Schunkert H, et al. Gammaglutamyl transferase and prognosis in patients with coronary artery disease. Clin Chim Acta. 2015 Nov 12
  9. Celik O, Cakmak HA, Satilmis S, Gungor B at al. The relationship between gamma-glutamyl transferase levels and coronary plaque burdens and plaque structures in young adults with coronary atherosclerosis. Clin Cardiol. 2014 Sep
  10. 37(9):552-7. 10.Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996
  11. Kato M, Hisatome I, Tomikura Yet al. Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 2005
  12. Biscaglia S, Ceconi C, Malagù M, Pavasini R, Ferrari R. Uric acid and coronary artery disease: An elusive link deserving further attention. Int J Cardiol. 2015 (15)30315- 6. 13.Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid tomortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995
  13. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease a